Research Paper Volume 13, Issue 3 pp 3269—3289
Geroprotective effects of Alzheimer’s disease drug candidates
Figure 6. The molecular pathways targeted by J147 and CMS121 are distinct between the brain and kidney. Summary of proteins with significantly altered levels with age that were corrected by compound treatment. Proteins are listed under their respective subcategory.